MURIEL LIGHTS' CANDLE DESIGNS

Tuesday, March 31, 2015

Muriel Lights' Candle Designs: Black Women Most At Risk For Stage 4 Breast Cancer...

Muriel Lights' Candle Designs: Black Women Most At Risk For Stage 4 Breast Cancer...: The National Cancer Institute release a study that state black women have been diagnosed with  the highest rate of breast cancer triple nega...

Black Women Most At Risk For Stage 4 Breast Cancer

The National Cancer Institute release a study that state black women have been diagnosed with the highest rate of breast cancer triple negative " stage four.  

This , new "nationwide" data may help doctors identify which patients are most at risk ... and which treatments are best. For the first time, researchers examined the four major types of breast cancer, "including" triple negative … then determined how often ethnicity and race, poverty levels, age, and other factors played a role.  

“This is just such a complex disease. We used to think of breast cancer as you were before or after menopause. It really is more about the biology of the cancer,” says Dr. Joanne Mortimer of City of Hope.

The research found non-Hispanic blacks had a higher rate of triple negative breast cancer and late stage disease than other racial groups.

“What kind of treatments are involved?” 

“So, usually, chemotherapy is a major component of it.”

The study also looked at other cancers and found lung, colorectal, and prostate cancers are down, but incidence of thyroid, kidney, and liver cancers are up for both men and women.

These findings newly released may be a surprise to others, but I find this news that should  not surprise anyone in our community that ethnicity and race, poverty levels, age, and other factors played a role.  When you have several family members who have died from cancer late stage


  • Non Hispanic, Black women
  • Healthcare finding out diagnosis late stage/Health Education knowing how to examine breast /Health prevention  getting annual cancer check up black women are usually more obese and have more breast density 
  • Factors such as heredity/ reconstructive choices 

tTriple negative is one of four subtypes of breast cancer, and a new report emphasizes how important it is for doctors to identify the risks and treatments for each. For example, triple negative cancers do not respond to certain hormonal therapies that can help other women.
The nationwide data -- published in the Journal of the National Cancer Institute and co-authored by the American Association of Central Cancer Registries, the American Cancer Society, the Centers for Disease Control and Prevention, and the National Cancer Institute at the National Institutes of Health -- may help doctors identify which patients are at most risk for each type of breast cancer and which treatments may be most effective.
The data also also confirmed the previous finding that non-Hispanic white women are more likely to develop HR+/HER2- breast cancer, the least aggressive subtype, than women of other races and ethnicities. The study found that rates of HR+/HER2- breast cancer increased with increasing levels of poverty for every racial and ethnic group.






References

http://www.ktvn.com/story/28653901/improved-breast-cancer-screening
 ttp://www.breastcancer.org/symptoms/diagnosis/staging#stage0 


Monday, March 16, 2015

Muriel Lights' Candle Designs: Screening for Colorectal Cancer March 2015

Muriel Lights' Candle Designs: Screening for Colorectal Cancer March 2015: Add caption

Screening for Colorectal Cancer March 2015

Infographic titled Colorectal Cancer Screening: It’s the Right Choice. The text on the infographic is reproduced below.
Add caption

Muriel Lights' Candle Designs: March is Colorectal Cancer Awareness Month

Muriel Lights' Candle Designs: March is Colorectal Cancer Awareness Month: Among cancers that affect both men and women,   colorectal cancer   (cancer of the colon or rectum) is the second leading cause of cancer d...

March is Colorectal Cancer Awareness Month

Among cancers that affect both men and women, colorectal cancer (cancer of the colon or rectum) is the second leading cause of cancer deaths in the United States. Every year, about 140,000 Americans are diagnosed with colorectal cancer, and more than 50,000 people die from it. But this disease is highly preventable, by getting screened beginning at age 50

Things you should know

·         Screening should be done between the ages  50 t0 75 regularly.  Screening tests help prevent colorectal cancer by finding precancerous polyps (abnormal growths) so they can be removed. Screening also finds this cancer early, when treatment can be most effective.
·         Be physically active.
·         Maintain a healthy weight.
·         Don’t drink too much alcohol.
·         Don’t smoke.

 Fast Facts

·         Risk increases with age. More than 90% of colorectal cancers occur in people aged 50 and older.
·         Precancerous polyps and colorectal cancer don’t always cause symptoms, especially at first. You could have polyps or colorectal cancer and not know it. That is why having a screening test is so important. If you have symptoms, they may include—
o    Blood in or on the stool (bowel movement).
o    Stomach pain, aches, or cramps that do not go away.
o    Losing weight and you don’t know why.
These symptoms may be caused by something other than cancer. If you have any of them, see your doctor.
·         Some people are at a higher risk than others for developing colorectal cancer. If you think you may be at high risk, talk to your doctor about when and how often to get tested.
·         There are several screening test options. Talk with your doctor about which is right for you.
o    Colonoscopy (every 10 years).
    • High-sensitivity fecal occult blood test (FOBT), stool test, or fecal immunochemical test (FIT) (every year).
    • Sigmoidoscopy (every 5 years, with FOBT every three years).                                                                                             Reference                                                                                  http//cdc.gov/cancer/dcpc/resources/featurescoloroctalwareness/

/